Influenza

Feature Article

Improving Efforts to Prepare for Influenza Epidemics

Improving Efforts to Prepare for Influenza Epidemics

Although substantial emphasis is placed on vaccinations in considering how to limit the spread of influenza, simple hygienic methods have been found to be the most effective and should be more widely supported.

Latest News

AAP Recommends Shot Over Nasal Spray for 2018-2019 Flu Season

AAP Recommends Shot Over Nasal Spray for 2018-2019 Flu Season

The advisory comes early as physicians are currently placing vaccine orders.

Flu Vaccines Have High Impact, Even With Relatively Low Efficacy

Flu Vaccines Have High Impact, Even With Relatively Low Efficacy

Even relatively low-efficacy influenza vaccines can have a high impact, especially with optimal distribution across age groups.

FDA to Review Fluzone Quadrivalent 0.5mL Dose for Younger Patients

FDA to Review Fluzone Quadrivalent 0.5mL Dose for Younger Patients

The sBLA included clinical data from a Phase 4 study that enrolled nearly 2000 children and assessed the safety and immunogenicity of the 0.5mL dose.

ACOG: Updated Recommendations for Influenza Vaccination During Pregnancy

ACOG: Updated Recommendations for Influenza Vaccination During Pregnancy

This updated Committee Opinion includes more recent data on the safety and efficacy of influenza vaccination during pregnancy, as well as recommendations for treatment and postexposure chemoprophylaxis.

Adult Caregivers Likely to Receive Influenza Vaccination From Pediatric Clinics

Adult Caregivers Likely to Receive Influenza Vaccination From Pediatric Clinics

Adult caretaker influenza vaccination cocooning programs can prove beneficial and financially successful in private practice models where external funding is limited or not available.

Inactivated Quadrivalent Flu Vaccine Highly Efficacious in Children Aged 6-35 Months

Inactivated Quadrivalent Flu Vaccine Highly Efficacious in Children Aged 6-35 Months

Study adds to the body of existing evidence to support universal vaccination of all children from 6 months of age, irrespective of risk status, to prevent influenza in this age group and to reduce the spread of influenza in the general population.

Efficacy of Adjuvanted vs Conventional Quadrivalent Flu Vaccine Compared

Efficacy of Adjuvanted vs Conventional Quadrivalent Flu Vaccine Compared

MF59 adjuvanted, quadrivalent influenza vaccine (aQIV) was found to be more efficacious in preventing influenza than a non-adjuvanted conventional influenza vaccine in children aged 6 through 23 months.

Increased Risk for Acute Respiratory Illness Following Influenza Vaccine in Children

Increased Risk for Acute Respiratory Illness Following Influenza Vaccine in Children

Among children there was an increased risk for acute respiratory illness caused by noninfluenza respiratory pathogens following influenza vaccination compared to unvaccinated children during the same period.

Temporary Methotrexate Discontinuation Improves Seasonal Influenza Vaccine Immunogenicity

Temporary Methotrexate Discontinuation Improves Seasonal Influenza Vaccine Immunogenicity

Discontinuing methotrexate for 2 weeks following flu vaccine may improve the immunogenicity of the vaccine in patients with rheumatoid arthritis.

Recombinant Influenza Vaccine Found to Be Safe in Children

Recombinant Influenza Vaccine Found to Be Safe in Children

Researchers compared the safety and immunogenicity of the quadrivalent, recombinant influenza vaccine vs the inactivated influenza vaccine in children and adolescents 6 to 17 years of age.

Sign Up for Free e-newsletters